Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure
NCT ID: NCT02128802
Last Updated: 2025-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2014-04-01
2024-03-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer
NCT04922307
The Outcomes of Living Donor Robotic Assisted Kidney Transplantation
NCT06577805
Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program
NCT06688825
Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review
NCT04182607
Access to Kidney Transplant of Obese Patients Beginning Dialysis
NCT04748770
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical Gastric Bypass
Patients will undergo surgical gastric bypass according to standard institutional protocols
Gastric Bypass
Medical Weight Loss Management
Patients will receive best practices medical management for weight loss under current institutional protocols
Weight Loss Program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gastric Bypass
Weight Loss Program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age less than 60 years
* Available support person
* Adequate insurance
* All other criteria required for renal transplantation
Exclusion Criteria
* Bipolar disorder
* Crohn's disease
* Human Immunodeficiency Virus
* Cirrhosis
* Prior weight loss surgery
* Prior mesh hernia repair
* Prior anti-reflux surgery
* Inability to walk 200 feet
* Significant coronary disease
* Significant lung disease - Fixed expiratory volume 1 less than 75% or on oxygen
* Addiction to alcohol or drugs
* Inability to quit smoking
* Jehovah's witness
* Non-compliance with dialysis regimen
* Previous renal transplant
* Non-English speaking
18 Years
59 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seth Karp
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seth Karp, MD
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
130912
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.